Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)

PHASE3RecruitingINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

December 31, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2026

Conditions
EncephalopathyErythropoietinNewborn Asphyxia
Interventions
DRUG

Erythropoietin

Erythropoietin injections (500u/kg) x 9 doses

OTHER

Supportive neonatal intensive care

Neonatal intensive care monitoring and support including ventilatory and inotropic support as clinically indicated

Trial Locations (10)

1000

RECRUITING

Bangabandhu Sheikh Mujib Medical University, Dhaka

Unknown

NOT_YET_RECRUITING

Dhaka Medical College, Dhaka

RECRUITING

Aurangabad Medical College, Aurangabad

RECRUITING

Bangalore Medical College, Bangalore

RECRUITING

Indira Gandhi Institute of Child Health, Bangalore

RECRUITING

Institute of Child Health, Madras Medical College, Chennai

RECRUITING

Kasturba Gandhi Medical College, Chennai

RECRUITING

Karnataka Institute of Medical Sciences, Hubli

RECRUITING

Lokmanya Tilak Municipal Medical College, Mumbai

NOT_YET_RECRUITING

University of Kelaniya, Kelaniya

All Listed Sponsors
lead

Imperial College London

OTHER